About Careers MedBlog Contact us
Medindia LOGIN REGISTER
Advertisement

Natco Pharma and Hetero Receives Indian Drug Regulatory Approval for Hepatitis-C Drug

by Reshma Anand on December 15, 2015 at 12:38 PM
Font : A-A+

Natco Pharma and Hetero Receives Indian Drug Regulatory Approval for Hepatitis-C Drug

Two Hyderabad-based drug companies, Natco Pharma and Hetero have received approval for the sale of Hepatitis- C drug from the Drugs Controller General of India (DCGI).

The generic version of the drug, Daclatasvir Dihydrochloride (Daclatasvir) is the first-in-class NS5A inhibitor used in combination with Sofosbuvir for the treatment of patients with chronic hepatitis C virus (HCV) genotype 3 infection.

Advertisement


Natco Pharma will sell the drug under its brand name 'NATDAC' and has received approval for two dosage levels, 60mg and 30 mg. The price is Rs, 6000 for 60mg and Rs. 4000 for 30 mg, for a bottle of 28 tablets.

"It is the first company in India to get approval for generic Daclatasvir Dihydrochloride (Daclatasvir) tablets, 30 mg & 60 mg, from the Drugs Controller General (India)," Natco said.
Advertisement

"Compared with other treatment options, this combination not only increases the cure rate, but is also regarded as a valuable treatment option in some of the difficult-to-treat HCV patients subsets," Natco added.

Hetero said its product is generic version of Bristol-Myers Squibb's Daklinza tablets.

"The product in combination with Sofosbuvir is indicated for the treatment of Hepatitis C genotype 3 infections, which is highly prevalent in India," Hetero added.

Source: Medindia
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
What's New on Medindia
Get Involved and Stand Up for Human Rights on Human Rights Day 2022
Coronary Artery Bypass Grafting
Macronutrients Calculator for Weight Loss
View all
Recommended Reading
News Archive
Date
Category
Advertisement
News Category

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Drug Toxicity Signature Drug Toxicity 

Most Popular on Medindia

Calculate Ideal Weight for Infants Selfie Addiction Calculator Drug Interaction Checker Accident and Trauma Care Hearing Loss Calculator The Essence of Yoga Drug Side Effects Calculator Diaphragmatic Hernia Post-Nasal Drip How to Reduce School Bag Weight - Simple Tips
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close
×

Natco Pharma and Hetero Receives Indian Drug Regulatory Approval for Hepatitis-C Drug Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests